Skip to main content

Garg Pushkal's Form 4 filing

Alnylam Pharmaceuticals, Inc. (ALNY) · filed Mar 5, 2025

Accession no.
0001735276-25-000032
Filed
Mar 5, 2025
Trade date
Mar 3-4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $621.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Garg PushkalCIK 0001829252Officer (CMO & EVP Dev & Med Affairs)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockAGrant or awardAcquired+14,137$0.00$027,099Direct
Mar 3, 2025Common StockSSaleDisposed−213$242.37F4−$51,624.8126,886Direct
Mar 3, 2025Common StockSSaleDisposed−235$243.36F5−$57,189.626,651Direct
Mar 3, 2025Common StockSSaleDisposed−158$244.41F6−$38,616.7826,493Direct
Mar 3, 2025Common StockSSaleDisposed−116$245.26F7−$28,450.1626,377Direct
Mar 3, 2025Common StockSSaleDisposed−48$246.18F8−$11,816.6426,329Direct
Mar 3, 2025Common StockSSaleDisposed−5$247.35F9−$1,236.7526,324Direct
Mar 3, 2025Common StockSSaleDisposed−1$248.36−$248.3626,323Direct
Mar 3, 2025Common StockSSaleDisposed−583$243.13F11−$141,744.7925,740Direct
Mar 3, 2025Common StockSSaleDisposed−273$244.43F12−$66,729.3925,467Direct
Mar 3, 2025Common StockSSaleDisposed−117$245.53F13−$28,727.0125,350Direct
Mar 4, 2025Common StockSSaleDisposed−147$239.25F14−$35,169.7525,203Direct
Mar 4, 2025Common StockSSaleDisposed−343$240.92F15−$82,635.5624,860Direct
Mar 4, 2025Common StockSSaleDisposed−198$241.60F16−$47,836.824,662Direct
Mar 4, 2025Common StockSSaleDisposed−120$242.70F17−$29,12424,542Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2025Common StockAGrant or awardAcquired+7,819$0.00$07,819Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.87 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.89 to $243.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $244.91 to $245.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $246.00 to $246.71. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $247.04 to $247.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.62 to $243.58. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F12

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $244.04 to $244.80. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F13

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $245.07 to $245.74. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F14

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F15

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F16

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.21 to $242.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F17

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.46 to $242.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)